Production (Stage)
ProQR Therapeutics N.V.
PRQR
$1.91
$0.126.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 143.12M | 154.68M | 99.71M | 103.02M | 110.81M |
| Total Receivables | 2.98M | 2.10M | 1.46M | 4.87M | 3.40M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.15M | 2.50M | 1.91M | 1.14M | 1.39M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 149.24M | 159.28M | 103.07M | 109.04M | 115.61M |
|
|
|||||
| Total Current Assets | 149.24M | 159.28M | 103.07M | 109.04M | 115.61M |
| Net Property, Plant & Equipment | 14.71M | 14.61M | 16.10M | 17.45M | 18.04M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 163.95M | 173.89M | 119.17M | 126.49M | 133.65M |
|
|
|||||
| Total Accounts Payable | 447.50K | 16.60K | 34.60K | 35.40K | 357.10K |
| Total Accrued Expenses | 519.90K | 1.53M | 1.53M | 1.55M | 1.47M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.61M | 6.37M | 6.58M | 6.55M | 6.31M |
| Total Finance Division Other Current Liabilities | 28.87M | 32.36M | 36.07M | 31.81M | 28.99M |
| Total Other Current Liabilities | 28.87M | 32.36M | 36.07M | 31.81M | 28.99M |
| Total Current Liabilities | 36.44M | 40.28M | 44.21M | 39.94M | 37.13M |
|
|
|||||
| Total Current Liabilities | 36.44M | 40.28M | 44.21M | 39.94M | 37.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.61M | 11.46M | 12.83M | 14.01M | 14.43M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 30.59M | 30.47M | 34.27M | 37.33M | 44.52M |
| Total Liabilities | 78.64M | 82.20M | 91.31M | 91.29M | 96.08M |
|
|
|||||
| Common Stock & APIC | 85.32M | 505.35M | 464.46M | 446.20M | 449.27M |
| Retained Earnings | -- | -442.24M | -466.23M | -439.89M | -440.38M |
| Treasury Stock & Other | -- | 28.57M | 29.63M | 28.90M | 28.68M |
| Total Common Equity | 85.32M | 91.69M | 27.86M | 35.20M | 37.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 85.32M | 91.69M | 27.86M | 35.20M | 37.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 85.32M | 91.69M | 27.86M | 35.20M | 37.57M |
|
|
|||||